We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Powered Smart Stethoscope Can Screen for Heart Failure During Physical Exams

By HospiMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: Eko Smart Stethoscope (Photo courtesy of Eko)
Image: Eko Smart Stethoscope (Photo courtesy of Eko)

An independent study has validated the first artificial intelligence (AI)-powered device to screen for heart failure during a standard physical exam.

The study conducted by Eko (Oakland, CA, USA) and the Imperial College of London (London, UK), in conjunction with the UK National Health Service, has highlighted Eko's ability to screen patients for heart failure in seconds with AI during physical exams. Eko's low ejection fraction algorithm (ELEFT) detects a weakened heart pump, which is present in about half of heart failure patients.

In the study, the algorithm's performance at detecting a weak heart pump was excellent compared to the current gold standard of echocardiography. Approximately 26 million people are estimated to have heart failure worldwide. Diagnosis is a significant challenge given that heart failure symptoms are also associated with many other conditions and detection often requires a series of expensive tests. Using the Eko DUO ECG + Digital Stethoscope with ELEFT, heart failure caused by a weakened heart pump can be detected in seconds during a stethoscope exam.

The study found that when 15-second recordings were taken with the DUO at one chest location, the algorithm was 81% accurate at identifying normal and impaired heart pumping function. Accuracy went up to 86% when two recording locations were used. The tool will be submitted to the FDA under "Breakthrough Designation" for a formal review later this year.

"This tool allows healthcare professionals to reliably rule in or rule out heart failure at the point of care," said Dr. Nicholas Peters, Professor of Cardiology, Imperial College London. "The result will be earlier diagnosis and treatment and the avoidance of unnecessary and expensive tests for those in whom heart failure is ruled out. This means better and more cost-effective healthcare. It's a total game-changer."

"The superhuman capability to screen patients at any point of care, including before surgery, should challenge the unacceptable reality that 80% of patients with heart failure are currently diagnosed through an emergency hospital admission," said Dr. Patrick Bachtiger, lead author and a clinical research fellow at the UK's National Heart and Lung Institute. "The current clinical pathway simply misses too many patients, leaving them undiagnosed until very sick. This tool can save time and money and unlock major benefits for patients through early diagnosis and effective treatments."

"This is a landmark study for multiple reasons," said Dr. Adam Saltman, Chief Medical Officer at Eko. "The investigators showed that the low ejection fraction detection algorithm can quickly, easily, and effectively identify the patients who have impaired heart pumping function, even if those patients don't yet have symptoms."

Related Links:
Eko 
Imperial College of London 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mobile Cart
MS400
New
Digital Brain Electric Activity Mapping Device
KT88

Print article

Channels

Critical Care

view channel
Image: The new biomaterial mimics a key building block of human tissue, extracellular matrices, which act like scaffolding and enable cells to heal after damage (Photo courtesy of Sheikhi Research Group/Penn State)

Novel ‘Living’ Biomaterial to Advance Regenerative Medicine

Materials designed to replicate tissues and extracellular matrices (ECMs)—the biological frameworks made up of proteins and molecules that support tissues and cells—have traditionally faced challenges... Read more

Surgical Techniques

view channel
Image: The KeyScope low-cost laparoscope enables high resolution surgical imaging (Photo courtesy of Barnes et al., doi 10.1117/1.BIOS.2.2.022302)

Low-Cost, Robust Laparoscope Addresses Cost, Power and Sterilization Challenges

Laparoscopic surgery, a minimally invasive technique, has revolutionized surgical practices in high-income countries. This method involves using a laparoscope to perform operations through small incisions,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.